Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Divalproex for Late-Life Bipolar Mania (GERI-BD)
NCT00254488Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Nov 2005
- Primary completion
- Aug 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of lithium and divalproex sodium in bipolar disorder (BD), sponsored by Weill Cornell Medicine. Primary endpoint: Sedation Score at Week 9. Started Nov 2005; status: completed.
02
Drugs
lithiumdivalproex sodium
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00254488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254488.